CLP100: [UNIT: 050420]:[A1]: Comment on Criteria for Lung Cancer Screening and the Screening options in low resource settings

Describe the challenges you face in your clinical practice while screening for lung cancer and optimal preventive methods that can …

5Maximum Marks

ENDED Time Remaining Hours Minutes

CLP100: ICI LUNG CANCER PRECEPTORSHIP
Excellent course 5
Excellent course
CSP100: ICI SICKLE CELL DISEASE PRECEPTORSHIP
5
Very informative. Thank you.
Hilda odeny
CMP100: ICI MULTIPLE MYELOMA PRECEPTORSHIP
The Role of Pathology in Multiple Myeloma 5
Teresa Lotodo gave a good introduction to this lecture by defining MM and other plasma dyscrasias. She dwelt on diagnosis, risk stratification, staging and monitoring of MM. Of interest to me was her discourse on IHC and FISH. The use of CD markers to identify the clonality of the abnormal plasma cells. She also discussed bone marrow aspiration, indications, possible sites, processing of tissues, preparation of slides and reading of the slides by pathologists. There were pictures and charts to aid understanding of her lectures. It was well delivered and I learnt a lot. Thank you.
Dr. Angela Ogechukwu Ugwu
CSP100: ICI SICKLE CELL DISEASE PRECEPTORSHIP
5
Its a helpful platform for learning
Hellen moraa patrick
CBP100: ICI BREAST CANCER PRECEPTORSHIP
Well covered 4
In depth coverage of the topic was done, with good organization and a variety of experts involved in the care of breast cancer patient. The course also had a good balance between local and worldwide data and practices. Consider group discussion on real life patients amongst fellow course participants in future.